Related Experiment Video
Updated: May 28, 2026

Protein Purification-free Method of Binding Affinity Determination by Microscale Thermophoresis
Published on: August 15, 2013
Characterization of a Cytokine-Independent STAT5 Activator
Grace A Aleck1,2, Yena Jin1, Zehui Gu1
1Department of Pharmacology, University of Michigan, Ann Arbor, MI 48109, USA.
Abstract:
Background: Cytokine-induced JAK-STAT signaling becomes dysregulated in chronic human diseases, including cancer and autoimmunity, and contributes to immune cell dysfunction. A cytokine-independent approach to activating STAT proteins could "hardwire" pro-survival and effector programs in immune cells to sustain function within diseased tissues. Engineered variants of the herpesvirus saimiri tyrosine kinase interacting protein (TIP) can recruit the SRC family kinase (SFK) LCK to drive STAT phosphorylation and activation. Here, we evaluated the interactome of a TIP-derived, cytokine-independent STAT5 activator and determined whether it could induce STAT5 activation in immune cell lines and primary human CD8+ T cells. Methods: A STAT5 activator (aSTAT5) was characterized by proteomics using affinity purification mass spectrometry (AP-MS) to define its interactome and STAT5 binding specificity. STAT5 phosphorylation was assessed in hematopoietic cell lines and primary human CD8+ T cells. Results: Proteomic analysis confirmed preferential association of aSTAT5 with STAT5 relative to other proteins. In cell-based assays, aSTAT5 induced robust STAT5 phosphorylation in LCK-expressing NK-92 and Jurkat T cells, whereas phosphorylation was not observed in Raji B cells or RAW 264.7 macrophages despite expression of closely related SFKs and STAT5. Cytokine-independent STAT5 phosphorylation supported the viability of NK-92 cells and primary human CD8+ T cells during cytokine withdrawal and preserved the cytotoxic function of CAR T cells. Conclusions: We defined the interactome of a cytokine-independent STAT5 activator and demonstrated its capacity to maintain survival and function in human CD8+ T cells and NK-92 cells. These findings underscore the translational potential of engineered, cytokine-independent STAT5 activation for immune cell therapies.
Insights
Engineered STAT5 activators can bypass cytokine dependence to enhance immune cell survival and function. This approach shows promise for immune cell therapies in chronic diseases.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Janus kinase-Signal transducer and activator of transcription (JAK-STAT) signaling is crucial for immune function but dysregulated in diseases like cancer and autoimmunity.
- Activating STAT proteins independently of cytokines could improve immune cell persistence and efficacy in diseased tissues.
Purpose of the Study:
- To characterize the interactome of a novel, engineered cytokine-independent STAT5 activator (aSTAT5).
- To assess the ability of aSTAT5 to induce STAT5 activation in various immune cells, including primary human CD8+ T cells.
- To evaluate the functional impact of aSTAT5-mediated STAT5 activation on immune cell survival and function.
Main Methods:
- Proteomics, specifically affinity purification mass spectrometry (AP-MS), was used to define the aSTAT5 interactome and binding specificity.
- STAT5 phosphorylation was measured in hematopoietic cell lines (NK-92, Jurkat, Raji B, RAW 264.7) and primary human CD8+ T cells.
- Cell viability and cytotoxic function assays were performed under cytokine-deprived conditions.
Main Results:
- Proteomic analysis confirmed aSTAT5 preferentially binds STAT5.
- aSTAT5 induced robust STAT5 phosphorylation in LCK-expressing NK-92 and Jurkat T cells, but not in Raji B cells or RAW 264.7 macrophages.
- Cytokine-independent STAT5 activation by aSTAT5 enhanced NK-92 and CD8+ T cell viability and preserved CAR T cell function during cytokine withdrawal.
Conclusions:
- The interactome of the engineered STAT5 activator aSTAT5 was successfully defined.
- aSTAT5 demonstrates the capacity to activate STAT5 independently of cytokines, maintaining survival and function in human CD8+ T cells and NK-92 cells.
- Engineered cytokine-independent STAT5 activation holds significant translational potential for advancing immune cell-based therapies.
Related Concept Videos
The JAK-STAT Signaling Pathway
Co-activators and Co-repressors
Co-activators and Co-repressors
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
RNA Polymerase II Accessory Proteins
